Repositioning of bromocriptine for treatment of acute myeloid leukemia

BACKGROUND: Treatment for acute myeloid leukemia (AML) has not significantly changed in the last decades and new therapeutic approaches are needed to achieve prolonged survival rates. Leukemia stem cells (LSC) are responsible for the initiation and maintenance of AML due to their stem-cell propertie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara-Castillo, María Carmen, Cornet-Masana, Josep Maria, Etxabe, Amaia, Banús-Mulet, Antònia, Torrente, Miguel Ángel, Nomdedeu, Meritxell, Díaz-Beyá, Marina, Esteve, Jordi, Risueño, Ruth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015257/
https://www.ncbi.nlm.nih.gov/pubmed/27604463
http://dx.doi.org/10.1186/s12967-016-1007-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015257/
https://www.ncbi.nlm.nih.gov/pubmed/27604463
http://dx.doi.org/10.1186/s12967-016-1007-5

Ejemplares similares